Roger Hurst serves as Executive at AspenBio Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Roger Hurst has executed 8 insider transactions totaling $360.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 9, 2006 involved purchasing 2,000 shares valued at $2.9K.
Roger Hurst currently holds 1,799,500 shares of AspenBio Pharma, Inc. (APNB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roger Hurst has been a net buyer of APNB stock. They have purchased $360.2K and sold $0 worth of shares.
Roger Hurst's most recent insider trade was on Aug 9, 2006, when they purchased 2,000 shares at $1.43 per share.
Get notified when new Form 4 filings are submitted
| $1.41 |
| Discretionary |
| Aug 8, 2006 | APNB | $66.0K | Purchase | 46,500 | $1.42 | Discretionary |
| Jul 31, 2006 | APNB | $16.2K | Purchase | 10,500 | $1.54 | Discretionary |
| Jul 26, 2006 | APNB | $24.9K | Purchase | 17,500 | $1.42 | Discretionary |
| Jun 22, 2006 | APNB | $1.6K | Purchase | 1,000 | $1.60 | Discretionary |
| Jun 15, 2006 | APNB.OB | $5.6K | Purchase | 4,000 | $1.40 | Discretionary |
| Mar 7, 2006 | APNB | $222.0K | Purchase | 124,000 | $1.79 | Discretionary |